Home > Urology > EAU 2020 > BPH & LUTS > LUTS 2-year outcomes: aquablation versus TURP

LUTS 2-year outcomes: aquablation versus TURP

Presented By
Dr Neil Barber, Frimley Health NHS Foundation Trust, UK
EAU 2020
Phase 3, WATER
According to phase 3 trial results, aquablation demonstrated a significantly lower rate of sexual dysfunction compared with transurethral resection of the prostate (TURP) at the primary safety endpoint of 3 months. The 2-year outcomes of the WATER study were presented by Dr Neil Barber (Frimley Health NHS Foundation Trust, UK) [1]. This study compared the safety and efficacy of prostate ablation using aquablation therapy (i.e. robotic heat-free waterjet prostate resection) versus TURP for lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH). In this randomised, double blinded, global multicentre phase 3 trial, 184 men with moderate-to-severe LUTS related to BPH were assigned to aquablation therapy (n=117) or TURP (n=67). Baseline characteristics of patients in both arms were comparable, with no significant differences. The...

Please login to read the full text of the article.

If you have no account yet, please register now.

Posted on